Related Experiment Video
Updated: May 22, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Pharmacological actions of cardipro on cardiovascular system
S Chatterjee1, S N Das, S K Agrawala
1R& D Laboratory, Indian Herbs, Saharanpur - 247 001 Uttar Pradesh, India.
Insights
CARDIPRO, a novel formulation, demonstrates significant cardiovascular benefits. It lowers blood pressure, dilates blood vessels, and enhances heart contractility, offering potential for managing cardiovascular diseases.
Area of Science:
- Pharmacology
- Cardiovascular Medicine
- Biochemistry
Background:
- Cardiovascular diseases remain a leading cause of mortality worldwide.
- There is a continuous need for effective therapeutic agents to manage various cardiovascular disturbances.
- CARDIPRO is a polyhedral anti-oxidant and cardiotonic formulation proposed for cardiovascular health.
Purpose of the Study:
- To investigate the pharmacological effects of CARDIPRO on cardiovascular responses.
- To evaluate its potential as a therapeutic agent for cardiovascular diseases.
Main Methods:
- In vivo studies: assessed hypotensive effects in dogs and rabbits, and adrenaline potentiation.
- In vitro studies: examined effects on perfused frog blood vessels, isolated amphibian and mammalian hearts, and isolated rat auricles.
- Electrocardiogram (ECG) and coronary perfusion flow measurements were conducted.
Main Results:
- CARDIPRO induced hypotension in dogs and rabbits, an effect blocked by atropine.
- It potentiated and prolonged adrenaline's hypotensive action.
- Peripheral vasodilation was observed in frog blood vessels.
- Positive ionotropic and negative chronotropic effects were noted on isolated hearts.
- Enhanced contractility in rat auricles and increased coronary perfusion flow in rabbit hearts were observed.
- No significant per se effect on rabbit ECG.
Conclusions:
- CARDIPRO exhibits significant cardiotonic, peripheral vasodilating, and coronary vasodilating properties.
- These combined effects suggest CARDIPRO's potential utility in the management of cardiovascular diseases.
Abstract:
CARDIPRO is a polyhedral anti-oxidant and cardiotonic formulation recommended to be used in various cardiovascular disturbances, effect of CARDIPRO on different in vitro and in vivo cardiovascular responses were studied. CARDIPRO produced hypotensive effect in dogs and rabbits. The effect was blocked by prior atropinization, CARDIPRO also potentiated and prolonged the beta receptor mediated hypotensive action of adrenaline in dogs. CARDIPRO was found to produce peripheral vasodilation in perfused frog blood vessels, CARDIPRO exerted positive ionotrpic and negative chronotropic effects on perfused amphibian and mammalian heart (isolated and in situ) it also produced transient positive ionotrpic effect on hypodynamic frog hert. CARDIPRO enhanced the amplitude of contractive response of isolated rat auricle. CARDIPRO did not produce an per se effect on electrocardiogram of rabbits, CARDIPRO enhanced both basal and maximum coronary perfusion flow in isolated perfused rabbi hert. The cardiotonic properly of CARDIPRO along with its peripheral and coronary vasodiating effects may greatly help in management of carediovascular diseases.
Related Concept Videos
Pathophysiology of Cardiac Performance
Cardiovascular Drugs: Classification based on Therapeutic Indications
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Heart Failure Drugs: β-Blockers
Heart Failure Drugs: Inotropic Agents
